References
- Rosebush P, Stewart T: A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry 1989; 146:717–725.
- Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989; 50:18–25.
- Grant R: Neuroleptic malignant syndrome. Brit Medi J 1984;288:1960.
- Burch EA, Downs J: Development of neuroleptic malignant syndrome during simultaneous amoxapine treatment and al-prazolam discontinuation. J Clin Psychopharrnacol 1987; 7:55–56.
- Lesaca T: Amoxapine and neuroleptic malignant syndrome. American J Psychiatry 1987; 144:1514.
- Baca L, Martinelli L: Neuroleptic malignant syndrome: A unique association with a tricyclic antidepressant. Neurology 1990; 1797–1798.
- Addonizio G, Susman VL: Neuroleptic Malignant Syndrome: A Clinical Approach, Mosby Year Book, Inc.: St. Louis, MO. 1991:34–42.
- Addonizio G, Susman VL, Roth SD: Symptoms of Neurolep-tic Malignant syndrome in 82 consecutive inpatients. Am J Psychiatry 1986; 143:1587–1590.
- Spring G, Frankel M: New data on lithium and haloperidol incompatibility. Am J Psychiatry 1981; 138:818–821.
- Caroff SN: The neuroleptic malignant syndrome. J Clin Psy-chiatry 1980; 79–83.
- Addonizio G, Susman VL: Neuroleptic Malignant Syndrome: A Clinical Approach. Mosby Year Book, Inc.: St. Louis, MO. 1991:7–17.
- Primeau F, Fontaine R, Choitinard G: Poorly controlled EPS: Risk factors for NMS. Canad J Psychiatry 1987; 32:328–321.
- Schvehla TJ, Herjanic M: Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs. J Clin Psychiatry 1988; 49:283–284.
- Catterson ML, Martin RL: Antichoinergic toxicity masqu-erading as neuroleptic malignant syndrome: A case report and review. Annals Clini Psychiatry 1994; 6:267–269.
- Guze BH, Ferng H, Szuba MP, Richeimer SH: Antidepres-sants. In The Psychiatric Handbook. Mosby-Year Book, Inc., St. Louis, MO. 1995:55–56.
- Webster P, Wijeratne C: Risperidone-induced neuroleptic malignant syndrome. Lancet 1994; 344:1288–1229.
- Raitasuo V. Risperidone-induced neuroleptic malignant syn-drome in a young patient. Lancet 1994; 344:1705.
- Tarsy D: Risperidone and neuroleptic malignant syndrom. JAMA 1996; 275:446.
- Levenson JL: Neuroleptic malignant syndrome after the initia-tion of olanzapine. J Clin Psychopharmacol 1999; 19:477–478.
- Gheorghiu S, Knobler HY, Drumer D: Recurrence of neuro-leptic malignant syndrome with olanzapine treatment. Am J Psychiatry 1998; 155:1836.